Background. Longevity of the superior cavopulmonary connection (SCPC) is limited by the development of pulmonary arteriovenous malformations (PAVM). The goal of this study was to determine whether phenotypic changes in pulmonary artery endothelial cells (PAEC) that favor angiogenesis occur with PAVM formation.
Background. Longevity of the superior cavopulmonary connection (SCPC) is limited by the development of pulmonary arteriovenous malformations (PAVM). The goal of this study was to determine whether phenotypic changes in pulmonary artery endothelial cells (PAEC) that favor angiogenesis occur with PAVM formation.
Methods. A superior vena cava to right pulmonary artery connection was constructed in 5 pigs. Pulmonary arteries were harvested at 6 to 8 weeks after surgery to establish cultures of PAEC and smooth muscle cells, to determine cell proliferation, gene expression, and tubule formation. Abundance of proteins related to angiogenesis was measured in lung tissue.
Results. Contrast echocardiography revealed right-toleft shunting, consistent with PAVM formation. While the proliferation of smooth muscle cells from the right pulmonary artery (shunted side) and left pulmonary artery (nonshunted side) were similar, right PAEC proliferation was significantly higher. Expression profiles of genes encoding cellular signaling proteins were higher in PAECs from the right pulmonary artery versus left pulmonary artery. Protein abundance of angiopoietin-1, and Tie-2 (angiopoietin receptor) were increased in the right lung (both p < 0.05). Tubule formation was increased in endothelial cells from the right pulmonary artery compared with the left pulmonary artery (404 ± 16 versus 199 ± 71 tubules/mm 2 , respectively; p < 0.05).
Conclusions. These findings demonstrate that PAVMs developed in a clinically relevant animal model of SCPC concomitantly with differential changes in PAEC proliferative ability and phenotype. Moreover, there was a significant increase in the angiopoietin/Tie-2 complex in the right lung, which may provide novel therapeutic targets to attenuate PAVM formation after a SCPC.
(Ann Thorac Surg 2013;96:1442-9) Ó 2013 by The Society of Thoracic Surgeons T he superior cavopulmonary connection (SCPC) has been shown to reduce mortality in infants with single ventricle disease before the Fontan procedure [1] . Importantly, some infants who remain palliated by a SCPC fare better than after a Fontan [2] , which often demonstrates significant late failures [3] . However, the durability of the SCPC is significantly limited owing to progressive cyanosis observed secondary to the development of pulmonary arteriovenous malformations (PAVM) [4] . Therefore, further understanding of factors that contribute to PAVM development may lead to therapies that improve outcomes for these infants.
PAVMs develop because of abnormalities in angiogenesis secondary to changes in blood flow patterns and alterations in the circulating milieu of proangiogenic and antiangiogenic factors [5] . The SCPC involves directing venous return from the superior vena cava to one (classic Glenn shunt) or both (bidirectional SCPC) lungs. This results in a loss of pulsatile flow through the pulmonary arteries (PA), and a change in shear stress and pressure loading conditions on the pulmonary vascular endothelium [6] , which may alter the cellular phenotype of pulmonary artery endothelial cells (PAEC) [7] . In addition, the redirection of venous return with a SCPC is associated with a loss of hepatic effluent to the lung, which has been proposed as a mechanism for PAVM formation after SCPC [4] contains a number of proteins that can promote or inhibit angiogenesis, or both [8] . Hepatic stellate cells secrete angiopoietins, which bind to specific receptors on endothelial cells (EC) and promote angiogenesis [9] . Conversely, plasminogen, produced by hepatocytes, is the precursor of angiostatin, a potent inhibitor of angiogenesis [10] . However, it remains unknown whether and to what degree these alterations in blood flow patterns or loss of hepatic effluent contribute to PAVM development.
Using a porcine model of unidirectional SCPC, we tested the hypothesis that PAVM formation occurs coincident with changes in the phenotypic and functional characteristics of PAEC or smooth muscle cells (SMC) or both, with the emergence of a proangiogenic signal or the loss of a preexisting antiangiogenic signal.
Material and Methods
A unidirectional SCPC was constructed in 5 female pigs (weight 27 kg to 31 kg) through a right thoracotomy. The superior vena cava and right pulmonary artery (RPA) were mobilized and the RPA was temporarily clamped and then completely divided at the bifurcation. The proximal end was sutured close and the distal end anastomosed to the superior vena cava using a 10 mm to 12 mm Gore-Tex (Gore Medical, Flagstaff, AZ) interposition graft (necessary due to unique porcine PA anatomy). This model results in a lack of pulsatile flow to the RPA and antegrade pulsatile flow to the left pulmonary artery (LPA). The left lung and LPA served as contralateral controls for the right lung and RPA. The lungs and PAs from 2 age-matched pigs were harvested and used as referent control specimens, which were used to account for changes in unknown factors that could influence the phenotype of PAECs from the LPA. Hemodynamic measurements including oxygen saturation was measured at baseline and during the terminal procedure. Animals were treated and cared for in accordance with the National Institutes of Health "Guide for the Care and Use of Laboratory Animals" (National Research Council, Washington, 1996) , and the Institutional Animal Care and Use Committee approved the protocol.
At 6 to 8 weeks after SCPC, contrast echocardiography and angiography were performed to ascertain PAVM formation. Right and left lung biopsies were obtained at each terminal experiment (n ¼ 7, 5 pigs with a SCPC and 2 referent controls), and stored in formalin for immunohistochemistry or flash frozen.
The PAEC and SMC were isolated from the RPA (RPA/ SCPC side; n ¼ 2 PAEC, n ¼ 3 SMC) and left (LPA/nonshunted side; n ¼ 3 PAEC, n ¼ 3 SMC) from the SCPC pigs. In addition, PAEC and SMC were isolated from the RPA (n ¼ 2 PAEC, n ¼ 2 SMC) and LPA (n ¼ 2 PAEC, n ¼ 2 SMC) from the referent controls. Each cell line was assayed in triplicate and values for each pig were averaged to form a single data point [11] . Briefly, the PAs were opened and the luminal surface scraped into porcine EC growth media (Cell Applications, San Diego, CA). The SMC from the PAs were cultured using the outgrowth technique [12] . The PAs were minced into 2 mm Â 2 mm pieces and cultured in Smooth Muscle Growth Media 2 (Promocell, Heidelberg, Germany) containing 20% FBS (Life Technologies, Grand Island, NY). The cells were incubated at 37 C, 5% CO 2 (21% O 2 ) and allowed to propagate until time of studies. All cell cultures were analyzed in early passages three through eight.
Cell Proliferation Assay
Cell proliferation was quantified utilizing the CyQuant Assay (Life Technologies). The PAEC and SMC were seeded in a 96-well plate (Corning Inc, Corning, NY) at a density of 5 Â 10 3 cells per well. Cells were then stained with 0.004% CyQuant Direct nucleic stain in phosphatebuffered saline and a direct background suppressor (0.02%) for 1 hour at 37 C with 5%CO 2 . Fluorescence (excitation/emission: 480/535 nm), which reflected the number of cells, was measured at standard timepoints of 24, 30, 44, 54, and 68 hours after seeding and expressed as a change in cell number from the 24-hour time point [13] .
Tubule Formation Assay
Tubule formation assay was performed to determine a functional phenotype for the EC [11] . The PAEC (1.2 Â 10 5 cells per well) were added to 24-well plates coated with basement membrane matrix (298 mL Matrigel, 9.2 mg/ml per well [BD Biosciences, San Jose, CA]). Cells were incubated at 37 C for 3 hours and imaged (2.5Â objective; Zeiss Axiovert, Gottingen, Germany). Number of tubules, length of the tubules, and nodes at which the tubules originated were identified using a tracking algorithm and quantified by image analysis (SigmaScan Pro 5; Systat Software, San Jose, CA).
Quantitative Polymerase Chain Reaction
The PAEC from the LPA and RPA from SCPC animals and controls were denatured to extract RNA, which was reverse transcribed to generate cDNA (RT 2 First Strand Kit; Qiagen, Hilden, Germany). The cDNA was stored Abbreviations and Acronyms AVM = arteriovenous malformations Ct = cycle threshold EC = endothelial cell ECM = extracellular matrix HIF = hypoxia inducible factor LPA = left pulmonary artery PA = pulmonary artery PAEC = pulmonary artery endothelial cell PAVM = pulmonary arteriovenous malformation RPA = right pulmonary artery SCPC = superior cavopulmonary connection SMC = smooth muscle cell VEGF = vascular endothelial growth factor at À80
C until analyzed by quantitative polymerase chain reaction. Each cDNA sample was loaded onto a customdesigned polymerase chain reaction array (Qiagen). The list of primers and gene sequences are provided in Appendix Table 1 . Each sample was amplified (CFX96; Bio-Rad, Hercules, CA) with gene specific primer/probe sets to determine the cycle threshold (C t ) value for the gene of interest. Negative controls were run to verify the absence of DNA contamination. The mean Ct value for two control genes, HPRT1 and GAPDH, were used to normalize the data and calculate relative expression levels using the DCt method [14] . The relative expression levels were calculated as a fold change from the control using the DDCt method. Fold changes greater than twofold and less than 0.5-fold were marked as statistically different. Genes were categorized as those related to extracellular matrix (ECM) degradation, ECM deposition, and cellular signaling. The sum of fold changes in the expression of genes in each category was computed and plotted on a three-axis matrix (radar plot), as previously described [14] .
Immunoblotting
Immunoblotting was performed on lung homogenates and PAEC cell lysates [15] . Lung tissue extracts and PAEC cell lysate (20 mg total protein) were subjected to electrophoretic separation and transferred to a nitrocellulose membrane. After blocking and washing, membranes were incubated for 1 hour in antisera corresponding to the specific analyte of interest (Appendix Table 2 ). Relative abundance of each analyte was analyzed by scanning densitometric methods using Gel-Pro Analyzer (Media Cybernetics, Silver Spring, MD) and normalized to b-actin values.
Statistical Analysis
For each analysis, the normality of data distribution across all groups was analyzed using the Shapiro-Wilk test. Data for any analyte not normally distributed was transformed before making statistical comparisons. Data points were expressed as a mean AE SD, and groups were compared using parametric statistics. Immunoblotting results were expressed as a percent change from referent control values (set to 100%). Comparisons were performed using a two-sided, one-sample t test. Changes in SMC and PAEC proliferation, and PAEC tube formation, were examined using a one-way analysis of variance. Because control RPA and LPA groups demonstrated no significant intergroup differences in proliferation, tube formation, or gene expression, control RPA and LPA results were combined to represent a single referent control group. Statistical procedures were performed using either BMDP (Cork, Ireland) or STATA (StataCorp, College Station, TX) software packages. Values of p less than 0.05 were considered statistically significant.
Results
At 6 to 8 weeks after creation of a SCPC, contrast echocardiography (Fig 1A) showed significant right-to-left shunting consistent with PAVM formation [16] . Pulmonary angiography demonstrated PAVMs in the right lung. There were no significant differences in oxygen saturations between controls and SCPC animals (98.0% AE 0.3% versus 91.6% AE 4.9%, p ¼ 0.23).
In lung homogenates (Fig 1B) , protein abundance of angiopoietin-1 and angiostatin were higher in the RPA group when compared with LPA and controls. However, abundance of Tie-2, vascular endothelial growth factor (VEGF), endoglin, and Kruppel-like factor (KLF-2 [shearstress responsive transcription factor]) were similar between groups. In addition, hypoxia-responsive factors, hypoxia-induced factor (HIF)-1a and hemoxygenase-1, were found to be similar between groups.
To examine the contribution of changes in cellular function toward PAVM development, RPA and LPA PAECs and SMCs were isolated and multiple primary cell lines were established from SCPC and controls. Key hallmarks of cellular phenotype were examined including proliferation, protein abundance, gene expression, and tube formation.
Cell Proliferation Assay
While the number of SMCs increased over time in each group of cell lines, no difference in growth rate was observed (Fig 2A) . The number and growth rate of PAEC in the RPA, however, increased significantly as compared with the LPA and controls (Fig 2B) : RPA (17.9 AE 12.9, p < 0.05) versus LPA (3.2 AE 2.0) or referent control (3.7 AE 0.7), expressed as percent change in cell number per hour. The RPA ECs were more prolific and there were a larger number of cells when plates were examined at similar times after plating (Fig 2C) . However, ECs from the LPA and RPA at the same confluence (similar number of cells) were morphologically similar (Fig 2D) .
Immunoblotting and Quantitative Polymerase Chain Reaction
Protein abundance of endoglin, KLF2, and Tie-2, were examined in each group of PAECs (Fig 3) . Abundance of endoglin ( Fig 3B) and Tie-2 levels ( Fig 3D) were increased in the RPA group when compared with the LPA and controls. However, abundance of KLF-2 was similar between all groups. When comparing expression profiles of genes involved in ECM deposition, ECM degradation, and cellular signaling, multiple genes displayed a differential pattern of expression in the ECs isolated from the RPA versus the LPA and control groups (Table 2, Appendix). When expressed as a radar plot (Fig 4) , the gene expression profile for the RPA was clearly different than that of the LPA group and control group, with a relative increase in the genes related to cellular signaling.
Tubule Formation
Photomicrographs from 3-hour tubule-formation assays are shown (Fig 5A) . There was a greater number of tubules formed by cells from the RPA versus the LPA and control within 3 hours of seeding. The number (Fig 5B) and total length of tubules ( Fig 5C) were higher in the RPA group versus LPA and controls (p < 0.05). However, the average lengths of tubules were not different between the groups (28 AE 1 mm versus 26 AE 1 mm). This demonstrated a greater angiogenic potential in the RPA group.
Comment
Creation of SCPC results in a loss of pulsatile blood flow and hepatic effluent [4, 6] . Both these factors can affect function and paracrine signaling in PAECs through modulation of angiogenesis [7, 17] . Changes in EC function have previously been associated with AVMs in the brain [11] . Contrast echocardiography in infants after SCPC has demonstrated right-to-left shunting through PAVM formation almost universally [18] . Consistent with this, creation of a SCPC in our study resulted in PAVM.
Concomitantly, RPA PAEC exhibited a phenotypic change with higher proliferation rates, increased abundance of angiogenic factors, and stable alterations in gene expression profile that translate into a faster rate of tubule formation as compared with the LPA or controls. Thus, for the first time, this study demonstrated that changes in PAEC phenotype are associated with PAVM formation induced by the SCPC, and identifies mediators that may provide novel targets to attenuate PAVM development.
Nonpulsatile flow after a SCPC has been implicated in PAVM development [6] . Alterations in shear stress and pressure loading conditions can alter EC phenotype [7] . To examine the contribution of shear stress in PAVM development, KLF-2 abundance was examined [19] . Levels were similar in lung tissue and isolated PAEC in the presence and absence PAVM. This suggests that shear-related changes did not contribute to PAVM development. However, we did not assess the effect of shear stress on SMC phenotype.
The rationale for using a porcine model was based on the similarities to the human cardiovascular system [20] . Previous studies have demonstrated PAVM development after a SCPC using other species [8, 17] . After SCPC creation in lambs, increased angiotensin II expression in lungs with PAVMs was observed [8] . Gene array analysis of lung homogenates in a rat model has previously demonstrated altered expression of angiogenic factors [17] . However, changes reported from both models were analyzed from lung tissue homogenates, which consist of diverse cell types. We measured the relative protein abundance of specific analytes in lung homogenates to examine changes between SCPC lungs and controls.
To more closely examine the role of the specific cell types involved in the aberrant angiogenesis leading to PAVMs, we isolated and cultured primary PAEC and SMC. When we examined protein analytes in isolated cultures, we found increased levels of Tie-2 and endoglin (Fig 1B) , both endothelial specific markers, which were enriched by isolated cell cultures. Finding differential abundance of endoglin and Tie-2 in RPA versus LPA and controls provided significant evidence that the RPA PAEC phenotype was altered after the SCPC.
A role for altered oxidative stress in the development of PAVMs has been suggested [21] . Three groups were compared in an ovine model: SCPC, PA banding, and sham surgery with 30 minutes of RPA occlusion. The SCPC and PA banded cohorts had an increase in expression of oxidative stress genes HIF-1 and hemoxygenase-1 over the sham cohort. This finding suggested that PAVMs may result from hypoxia and increased oxidative stress. In our study, there were no differences in gene expression of these markers. Hypoxia and ischemia are known to induce HIF-1 [22] . Although in single ventricle patients this is indeed the case, the SCPC model was created in the setting of normal cellular and tissue oxygenation. Therefore, the lack of significant hypoxia does not support oxidative stress as an etiologic mechanism of PAVM formation.
Clinical evidence of the liver's role in PAVM development comes from heterotaxy patients who after a SCPC have hepatic venous blood diverted away from both lungs, and bilateral PAVMs develop [4] . Interestingly, these patients demonstrate dramatic resolution of PAVMs with redirection of hepatic venous return to the lungs [4] . Similarly, patients with end-stage liver disease have PAVMs, which resolve after liver transplant [23] . These findings suggest that PAVM development is associated with the absence of antiangiogenic factors or an increase in factors that promote angiogenesis in lungs with PAVMs. Proangiogenic factors include angiopoietin-1/Tie-2 complex and VEGF/VEGF receptor complex, whereas the antiangiogenic factors angiostatin and endostatin inhibit angiogenesis. A recent study observed decreased endostatin levels in patients with a SCPC [24] . Our study demonstrated that the expression of angiopoietin-1 was increased in lung homogenates from SCPC pigs as compared with controls. We examined endostatin abundance in lung homogenates and were unable to consistently detect a signal on immunoblots at the appropriate molecular weights. Together with the findings of PAEC proliferation and tubule forming capacity, these results demonstrate that PAVM formation is associated with an elevation of factors that promote angiogenesis.
Isolated ECs from human brain AVMs overexpress proangiogenic factors and proliferate faster than ECs in brains without AVMs [11] . Similarly, in our study PAEC from lungs with PAVM demonstrated a significantly higher proliferation rate than controls. Moreover, results from the tubule formation assay provided functional evidence of increased angiogenic potential in RPA ECs. The determination of a PAEC phenotype with respect to proliferation can provide a valuable in vitro test bed to determine fundamental mechanisms for PAVM development.
Hereditary hemorrhagic telangiectasia is an autosomal disorder characterized by multisystem vascular dysplasias with a high incidence of PAVM [25] . Mutations in endoglin, a receptor that binds transforming growth factor-b, have been identified with increased angiogenesis [25] . We found increased endoglin levels in the right lung. Gene expression profiles of the RPA PAEC demonstrated an increased expression of genes related to cellular signaling. Because the effect of selective inhibition of the transforming growth factor-b receptor has demonstrated inhibition of tumor proliferation and angiogenesis [26] , manipulation of this pathway may provide a means to attenuate pathological angiogenesis and PAVM formation.
Study Limitations
Although the LPA control within the SCPC animal accounts for lack of inferior vena cava effluent in the RPA, the control animals account for nonpulsatile flow in the SCPC. We did not exclusively account for the potential effects of temporary clamping during surgery. Changes in protein levels and PAEC phenotype were examined after PAVM formation, which therefore precluded the examination of fundamental processes that contribute to the initiation and progression of PAVMs. Follow-up studies will incorporate controls and timepoints accounting for these variables. A potential limitation of this study is that it was performed with a relatively small group of animals. and controls assembled into a number of nodes and tubule extension had commenced as evidenced by thin structures between nodes. In contrast, cells from the RPA-at the same timepoint-had assembled into a well-defined network structure between nodes, consistent with a more proangiogenic phenotype. (Photomicrographs were recorded using a 2.5Â objective with phase contrast.
Scale bars: 100 mm.) (B) Number of tubes and (C) total length of tubes were higher in the RPA than in the LPA (*p < 0.05 versus LPA).
Further, the SCPC was created in physiologically normal animals, which may not be an accurate reproduction of the human condition. Therefore, findings from this study would need to be validated in humans.
In conclusion, our findings suggest that PAVM formation after SCPC in pigs was associated with phenotypic changes in PAECs from the RPA. Although this study does not confirm the role of a hepatic factor, these alterations in PAEC proliferation rate, protein abundance, gene expression, and tubule formation play a mechanistic role in the development of PAVMs. Persistent changes in gene expression may provide novel therapeutic targets in the management of children with PAVMs after SCPC palliation. These results suggest that PAVM development is enhanced through the promotion of angiogenesis through the angiopoietin-1/Tie 2 pathway.
